L2 Asset Management LLC bought a new stake in Merck KGaA (OTCMKTS:MKGAF – Free Report) in the second quarter, Holdings Channel.com reports. The institutional investor bought 8,861 shares of the company’s stock, valued at approximately $1,139,000.
Several other large investors also recently added to or reduced their stakes in the business. Vega Investment Solutions acquired a new position in shares of Merck KGaA during the 2nd quarter worth $2,583,000. Cetera Trust Company N.A bought a new position in shares of Merck KGaA during the 2nd quarter valued at $906,000. Aberdeen Wealth Management LLC acquired a new stake in shares of Merck KGaA in the 2nd quarter valued at $193,000. Visionary Wealth Advisors acquired a new stake in shares of Merck KGaA in the 2nd quarter valued at $4,362,000. Finally, Cullen Capital Management LLC bought a new stake in Merck KGaA in the second quarter worth $259,158,000. 0.10% of the stock is owned by institutional investors.
Merck KGaA Trading Up 0.1%
Shares of OTCMKTS:MKGAF opened at $163.45 on Tuesday. The company has a current ratio of 1.31, a quick ratio of 0.84 and a debt-to-equity ratio of 0.27. The stock has a market capitalization of $21.12 billion, a PE ratio of 24.95 and a beta of 0.96. Merck KGaA has a 1 year low of $116.68 and a 1 year high of $175.56. The firm has a fifty day moving average price of $162.78 and a 200 day moving average price of $148.59.
Merck KGaA Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Further Reading
- Five stocks we like better than Merck KGaA
- Visa Just Put Hims & Hers in the Penalty Box—Here’s Why It Matters
- Treasury Yields Are Surging Again: 3 Stocks That Could Feel the Pain
- Snowflake Could Be Headed for New Highs Despite Insider Selling
- MongoDB Is Surging—And the Next Catalyst Is Almost Here
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
